The Metropolitan Area Agency on Aging is advising individuals who already have signed up for a Medicare plan to verify the plan's pricing information and other details with the insurer.
EnvisionRxPlus, a prescription drug plan, in an email sent last month to independent insurance brokers wrote that the tool did not provide accurate information for plans with deductibles that only apply to drugs on specific formulary tiers or for mail-order pharmacies, Inside Health Policy reports.
Medicare advisers and consumer advocates have expressed concerns that the full effect of the tool's inaccurate estimates might remain unclear until the 2020 coverage year begins and beneficiaries start to use their coverage.
Sen. Bob Casey (D-Pa.), the ranking member on the Senate Aging Committee, said he will ask CMS to offer beneficiaries who have experienced issues with the tool a second opportunity to sign up for coverage through a special open enrollment period.
As of Nov. 22, CMS had not published an alert warning users of the tool's potential inaccuracies.
Full article:
https://www.advisory.com/daily-briefing/2019/11/27/medicare-tool